FEASIBILITY AND INTERIM SAFETY AND EFFICACY ANALYSIS OF A FAST AUTOMATED PRODUCTION OF PROPHYLACTIC CMV-SPECIFIC CTLs AFTER ALLOGENEIC HSCT
{{output}}
Background: Cytomegalovirus (CMV) infection remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT). Although letermovir prophylaxis has reduced CMV reactivation in seropositive ... ...
